Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
MERIDIAN BIOSCIENCE INC (VIVO) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/28/2021 GN Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready™ LAMP Mix
04/19/2021 GN Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021
04/01/2021 GN Meridian Bioscience Announces FDA Submission for New Curian® Campy Assay
03/08/2021 GN Meridian Launches its New Air-Dryable Mix for Crude Blood Samples
02/23/2021 GN Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
02/23/2021 GN Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
02/16/2021 GN Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
02/05/2021 GN Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance
02/03/2021 GN Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown
02/02/2021 GN Meridian's Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays
01/06/2021 GN Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference
12/16/2020 GN Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2
12/08/2020 GN Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy